A 70-year-old man with newly diagnosed non-valvular atrial fibrillation is reviewed in clinic. He has well-controlled hypertension but no prior stroke, diabetes, heart failure or vascular disease. According to the Canadian CHADS-65 algorithm, what is the most appropriate antithrombotic strategy?